| Phage display as a technology delivering on the promise of peptide drug discovery M Hamzeh-Mivehroud, AA Alizadeh, MB Morris, WB Church, ... Drug discovery today 18 (23-24), 1144-1157, 2013 | 190 | 2013 |
| A simple improved desolvation method for the rapid preparation of albumin nanoparticles A Jahanban-Esfahlan, S Dastmalchi, S Davaran International journal of biological macromolecules 91, 703-709, 2016 | 165 | 2016 |
| Naproxen–eudragit® RS100 nanoparticles: Preparation and physicochemical characterization K Adibkia, Y Javadzadeh, S Dastmalchi, G Mohammadi, FK Niri, ... Colloids and Surfaces B: Biointerfaces 83 (1), 155-159, 2011 | 132 | 2011 |
| Synthesis and anti-leishmanial activity of 5-(5-nitrofuran-2-yl)-1, 3, 4-thiadiazol-2-amines containing N-[(1-benzyl-1H-1, 2, 3-triazol-4-yl) methyl] moieties A Tahghighi, S Razmi, M Mahdavi, P Foroumadi, SK Ardestani, S Emami, ... European journal of medicinal chemistry 50, 124-128, 2012 | 97 | 2012 |
| Overview of CD24 as a new molecular marker in ovarian cancer V Tarhriz, M Bandehpour, S Dastmalchi, E Ouladsahebmadarek, ... Journal of cellular physiology 234 (3), 2134-2142, 2019 | 85 | 2019 |
| Response surface methodology (RSM) modeling to improve removal of Cr (VI) ions from tannery wastewater using sulfated carboxymethyl cellulose nanofilter S Gasemloo, M Khosravi, MR Sohrabi, S Dastmalchi, P Gharbani Journal of Cleaner Production 208, 736-742, 2019 | 84 | 2019 |
| Antibody based EpCAM targeted therapy of cancer, review and update S Eyvazi, S Farajnia, S Dastmalchi, F Kanipour, H Zarredar, ... Current Cancer Drug Targets 18 (9), 857-868, 2018 | 81 | 2018 |
| Empagliflozin alleviates renal inflammation and oxidative stress in streptozotocin-induced diabetic rats partly by repressing HMGB1-TLR4 receptor axis ZA Jigheh, AG Haghjo, H Argani, L Roshangar, N Rashtchizadeh, ... Iranian journal of basic medical sciences 22 (4), 384, 2019 | 77 | 2019 |
| Degradation of trace aqueous 4-chloro-2-nitrophenol occurring in pharmaceutical industrial wastewater by ozone P Gharbani, M Khosravi, SM Tabatabaii, K Zare, S Dastmalchi, ... International Journal of Environmental Science & Technology 7, 377-384, 2010 | 75 | 2010 |
| Enhancement of dissolution rate and anti-inflammatory effects of piroxicam using solvent deposition technique M Barzegar-Jalali, N Maleki, A Garjani, AA Khandar, M Haji-Hosseinloo, ... Drug development and industrial pharmacy 28 (6), 681-686, 2002 | 74 | 2002 |
| Investigating the interaction of juglone (5-hydroxy-1, 4-naphthoquinone) with serum albumins using spectroscopic and in silico methods A Jahanban-Esfahlan, S Davaran, AA Moosavi-Movahedi, S Dastmalchi Journal of the Iranian Chemical Society 14, 1527-1540, 2017 | 73 | 2017 |
| QSPR models for the prediction of apparent volume of distribution T Ghafourian, M Barzegar-Jalali, S Dastmalchi, T Khavari-Khorasani, ... International journal of pharmaceutics 319 (1-2), 82-97, 2006 | 70 | 2006 |
| Synthesis and antileishmanial activity of novel 5-(5-nitrofuran-2-y1)-1, 3, 4-thiadiazoles with piperazinyl-linked benzamidine substituents A Tahghighi, FR Marznaki, F Kobarfard, S Dastmalchi, JS Mojarrad, ... European journal of medicinal chemistry 46 (6), 2602-2608, 2011 | 66 | 2011 |
| Histamine H3 receptor antagonists/inverse agonists: Where do they go? N Ghamari, O Zarei, JA Arias-Montaño, D Reiner, S Dastmalchi, H Stark, ... Pharmacology & Therapeutics 200, 69-84, 2019 | 57 | 2019 |
| Structural basis of simultaneous recruitment of the transcriptional regulators LMO2 and FOG1/ZFPM1 by the transcription factor GATA1 L Wilkinson-White, R Gamsjaeger, S Dastmalchi, B Wienert, PH Stokes, ... Proceedings of the National Academy of Sciences 108 (35), 14443-14448, 2011 | 57 | 2011 |
| Preparation of chitosan-plasmid DNA nanoparticles encoding interleukin-12 and their expression in CT-26 colon carcinoma cells F Lotfipour, S Hallaj-Nezhadi, H Valizadeh, S Dastmalchi, B Baradaran, ... Journal of Pharmacy & Pharmaceutical Sciences 14 (2), 181-195, 2011 | 57 | 2011 |
| Structural modelling and dynamics of proteins for insights into drug interactions T Werner, MB Morris, S Dastmalchi, WB Church Advanced drug delivery reviews 64 (4), 323-343, 2012 | 50 | 2012 |
| A simple and rapid protocol for producing yeast extract from Saccharomyces cerevisiae suitable for preparing bacterial culture media O Zarei, S Dastmalchi, M Hamzeh-Mivehroud Iranian journal of pharmaceutical research: IJPR 15 (4), 907, 2016 | 49 | 2016 |
| Solubility prediction for furosemide in water-cosolvent mixtures using the minimum number of experiments A Jouyban-Gharamaleki, S Dastmalchi, HK Chan, J Hanaee, ... Drug development and industrial pharmacy 27 (6), 577-583, 2001 | 49 | 2001 |
| Enhancing dissolution, serum concentrations and hypoglycemic effect of glibenclamide using solvent deposition technique S Dastmalchi, A Garjani, N Maleki, G Sheikhee, V Baghchevan, ... Journal of Pharmacy and Pharmaceutical Sciences 8 (2), 175-181, 2005 | 47 | 2005 |
